FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy is a research paper published in Journal of Cardiovascular Development and Disease (2024). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Deutsche Forschungsgemeinschaft
Grant: 24PRE1242192
Deutsche Forschungsgemeinschaft
Grant: F31DK127640
Deutsche Forschungsgemeinschaft
Grant: F31DK117550
Deutsche Forschungsgemeinschaft
Grant: F31DK115074
Deutsche Forschungsgemeinschaft
Grant: R01DK125459
Deutsche Forschungsgemeinschaft
Grant: R01HL145528
NIH HHS
Grant: 1F31DK127640-24A3
NIH HHS
Grant: 1R01DK125459-24A4
NIH HHS
Grant: 1R01HL145528-24A4
National Institutes of Health
Grant: 5F31DK127640-02
Hyperphosphatemia Contributes to Cardiac Injury in Chronic Kidney Disease
National Institutes of Health
Grant: 5F31DK115074-03
Vitamin D and soluble Klotho inhibit FGF23-mediated cardiac hypertrophy in Chronic Kidney Disease
National Institutes of Health
Grant: 1F31DK117550-01
FGF23 contributes to anemia in Chronic Kidney Disease by elevating hepcidin production
National Institutes of Health
Grant: 1R01DK125459-01
Hyperphosphatemia Contributes to Systemic Inflammation and Anemia in Chronic Kidney Disease
National Institutes of Health
Grant: 5R01HL145528-02
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)
Fields of Study
Keywords